Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Muhammad Zaeem Noman

Showing results (1-10 of 59) with videos related to

Pageof 6
Sort By:
Oncoimmunology|May 13, 2015
Targeting hypoxia at the forefront of anticancer immune responsesMuhammad Zaeem Noman, Salem Chouaib
Autophagy|January 26, 2018
Targeting autophagy blocks melanoma growth by bringing natural killer cells to the tumor battlefieldMuhammad Zaeem Noman, Guy Berchem, Bassam Janji
Medecine Sciences : M/S|May 8, 2014
[Tumor hypoxia: a key player in the regulation of stromal and anti-tumor responses]Meriem Hasmim, Yosra Messai, Muhammad Zaeem Noman, et al.
Cancer Letters|November 3, 2015
miR-210 and hypoxic microvesicles: Two critical components of hypoxia involved in the regulation of killer cells functionMuhammad Zaeem Noman, Bassam Janji, Guy Berchem, et al.
Bulletin Du Cancer|February 23, 2011
Cytotoxic T cells - stroma interactionsMuhammad Zaeem Noman, Houssem Benlalam, Meriem Hasmim, et al.
Cancer Microenvironment : Official Journal of the International Cancer Microenvironment Society|October 23, 2014
Crosstalk between CTC, Immune System and Hypoxic Tumor MicroenvironmentMuhammad Zaeem Noman, Yosra Messai, Jane Muret, et al.
Oncoimmunology|May 8, 2015
HIF-2α/ITPR1 axis: A new saboteur of NK-mediated lysisYosra Messai, Muhammad Zaeem Noman, Meriem Hasmim, et al.
Chimia|October 29, 2020
The 'Holy Grail' in Immuno-Oncology: AC BioScience SA is Aiming to Potentiate Anti-PD-1 Therapy Efficacy through Tumor Cell Conditioning StrategyAndreas Schläpfer, Christian Auclair, Bassam Janji, et al.
Oncoimmunology|September 18, 2018
Driving Natural Killer cells toward the melanoma tumor battlefield: Autophagy as a valuable therapeutic targetMuhammad Zaeem Noman, Jerome Paggetti, Etienne Moussay, et al.
Oncoimmunology|September 17, 2020
Firing up the cold tumors by targeting Vps34Bassam Janji, Meriem Hasmim, Santiago Parpal, et al.
Pageof 6

Showing results (1-10 of 59) with videos related to

Sort By:
Pageof 6
Oncoimmunology|May 13, 2015
Targeting hypoxia at the forefront of anticancer immune responsesMuhammad Zaeem Noman, Salem Chouaib
Autophagy|January 26, 2018
Targeting autophagy blocks melanoma growth by bringing natural killer cells to the tumor battlefieldMuhammad Zaeem Noman, Guy Berchem, Bassam Janji
Medecine Sciences : M/S|May 8, 2014
[Tumor hypoxia: a key player in the regulation of stromal and anti-tumor responses]Meriem Hasmim, Yosra Messai, Muhammad Zaeem Noman, et al.
Cancer Letters|November 3, 2015
miR-210 and hypoxic microvesicles: Two critical components of hypoxia involved in the regulation of killer cells functionMuhammad Zaeem Noman, Bassam Janji, Guy Berchem, et al.
Bulletin Du Cancer|February 23, 2011
Cytotoxic T cells - stroma interactionsMuhammad Zaeem Noman, Houssem Benlalam, Meriem Hasmim, et al.
Cancer Microenvironment : Official Journal of the International Cancer Microenvironment Society|October 23, 2014
Crosstalk between CTC, Immune System and Hypoxic Tumor MicroenvironmentMuhammad Zaeem Noman, Yosra Messai, Jane Muret, et al.
Oncoimmunology|May 8, 2015
HIF-2α/ITPR1 axis: A new saboteur of NK-mediated lysisYosra Messai, Muhammad Zaeem Noman, Meriem Hasmim, et al.
Chimia|October 29, 2020
The 'Holy Grail' in Immuno-Oncology: AC BioScience SA is Aiming to Potentiate Anti-PD-1 Therapy Efficacy through Tumor Cell Conditioning StrategyAndreas Schläpfer, Christian Auclair, Bassam Janji, et al.
Oncoimmunology|September 18, 2018
Driving Natural Killer cells toward the melanoma tumor battlefield: Autophagy as a valuable therapeutic targetMuhammad Zaeem Noman, Jerome Paggetti, Etienne Moussay, et al.
Oncoimmunology|September 17, 2020
Firing up the cold tumors by targeting Vps34Bassam Janji, Meriem Hasmim, Santiago Parpal, et al.
Pageof 6